Download
jbji-9-121-2024.pdf 554,66KB
WeightNameValue
1000 Titel
  • Local delivery of linezolid in the treatment of complex orthopedic bone and joint infections in patients with vancomycin allergy: a case series
1000 Autor/in
  1. Annasamudram, Abhijith |
  2. Janyavula, Aja |
  3. Elhessy, Ahmed H. |
  4. Shrestha, Raj Krishna |
  5. Gesheff, Martin |
  6. Conway, Janet D. |
1000 Verlag
  • Copernicus Publications
1000 Erscheinungsjahr 2024
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2024-03-22
1000 Erschienen in
1000 Quellenangabe
  • 9(2):121-126
1000 Copyrightjahr
  • 2024
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.5194/jbji-9-121-2024 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11106764/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • <jats:p>Abstract. Introduction: Osteomyelitis is a challenging bone infection associated with ischemia, trauma, or various surgical procedures (e.g., joint reconstruction). Treatment involves eradicating infected bone and soft tissue, local antibiotic delivery, and a 6-week course of antibiotics. Methicillin-resistant Staphylococcus aureus (MRSA) infections are common, and vancomycin is the standard treatment, but alternatives like linezolid are needed in vancomycin-resistant and vancomycin-allergic patients. Methods: A retrospective chart review was conducted on patients treated by the senior author between 2013 and 2021. The study included patients who received local delivery of linezolid for bone and/or joint infection with documented evidence of vancomycin allergy. Patient demographics, surgical details, linezolid delivery method, and outcomes were recorded. Clinical outcomes and subsequent procedures leading to infection eradication were documented. Results: A total of 13 patients were treated with linezolid-antibiotic-laden spacers with polymethyl methacrylate (PMMA) carrier. Nine patients were successfully treated using limb-salvage techniques and were still infection-free after a mean follow-up of 55.5 months. Conclusions: Linezolid-loaded bone cement is an option for managing chronic bone and joint infections, particularly MRSA, in patients with vancomycin allergy. </jats:p>
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/QW5uYXNhbXVkcmFtLCBBYmhpaml0aA==|https://frl.publisso.de/adhoc/uri/SmFueWF2dWxhLCBBamE=|https://frl.publisso.de/adhoc/uri/RWxoZXNzeSwgQWhtZWTCoEgu|https://frl.publisso.de/adhoc/uri/U2hyZXN0aGEsIFJhasKgS3Jpc2huYQ==|https://frl.publisso.de/adhoc/uri/R2VzaGVmZiwgTWFydGlu|https://frl.publisso.de/adhoc/uri/Q29ud2F5LCBKYW5ldMKgRC4=
1000 Hinweis
  • DeepGreen-ID: 988e2fb0c3164fe9908b9518d75f1a9b ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6480901.rdf
1000 Erstellt am 2024-05-23T17:37:15.081+0200
1000 Erstellt von 322
1000 beschreibt frl:6480901
1000 Zuletzt bearbeitet 2024-05-27T11:54:28.839+0200
1000 Objekt bearb. Mon May 27 11:54:28 CEST 2024
1000 Vgl. frl:6480901
1000 Oai Id
  1. oai:frl.publisso.de:frl:6480901 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source